Better outcome of high-dose ceftazidime in hemato – oncological patients with infections caused by extensively drug-resistant pseudomonas aeruginosa

Conclusion: Ceftazidime in high doses is a very potent ATB for the treatment of XDRP. aeruginosa infections in neutropenic cancer with acceptable toxicity.
Source: Mediterranean Journal of Hematology and Infectious Diseases - Category: Hematology Authors: Source Type: research